IPSEN (OTCMKTS:IPSEY) Shares Gap Down – Here’s What Happened

IPSEN (OTCMKTS:IPSEY) shares gapped down before the market opened on Monday . The stock had previously closed at $48.52, but opened at $45.7620. IPSEN shares last traded at $45.7620, with a volume of 539 shares traded.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on IPSEY. Zacks Research raised IPSEN to a “hold” rating in a research report on Friday, May 29th. HC Wainwright reaffirmed a “buy” rating on shares of IPSEN in a research report on Tuesday, June 30th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of IPSEN in a research note on Thursday, May 14th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

IPSEN Price Performance

The business’s 50-day moving average price is $46.90 and its 200 day moving average price is $44.69.

About IPSEN

Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.

The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).